CLOTRIMAZOLE 1%

CLOTRIMAZOLE 1% was reported 55 times

CLOTRIMAZOLE 1% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INSTILLATION SITE VESICLES 1 0.0588
1 DEVICE TEMPERATURE ISSUE 1 0.0133
2 CARDIOMETABOLIC SYNDROME 1 0.0105
3 PENILE BURNING SENSATION 1 0.0035
4 NASAL TURBINATE HYPERTROPHY 1 0.0027
5 INSTILLATION SITE ERYTHEMA 1 0.0019
6 COATING IN MOUTH 1 0.0019
7 GASTRIC NEOPLASM 1 0.0016
8 RUPTURED CEREBRAL ANEURYSM 1 0.0015
9 CHONDROCALCINOSIS 1 0.0015
10 PERFORATION 1 0.0012
11 INSTILLATION SITE REACTION 1 0.0009
12 BRONCHIAL HYPERREACTIVITY 1 0.0008
13 PENILE SWELLING 1 0.0008
14 TINEA PEDIS 1 0.0006
15 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 1 0.0005
16 COLOSTOMY 1 0.0005
17 LARGE INTESTINAL STENOSIS 1 0.0005
18 ENDOMETRIAL CANCER 1 0.0005
19 LARGE INTESTINAL OBSTRUCTION 1 0.0004
20 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
21 PRURITUS GENITAL 1 0.0004
22 INSTILLATION SITE PAIN 1 0.0004
23 ALCOHOL ABUSE 1 0.0004
24 PRODUCT RESIDUE PRESENT 2 0.0004
25 MONOCYTE COUNT INCREASED 1 0.0003
26 CHRONIC SINUSITIS 1 0.0003
27 FUNGAL SKIN INFECTION 1 0.0002
28 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
29 PERIPHERAL VENOUS DISEASE 1 0.0002
30 LUNG NEOPLASM 1 0.0002
31 RHINITIS ALLERGIC 1 0.0002
32 VAGINAL INFECTION 1 0.0002
33 CORONARY ARTERIAL STENT INSERTION 1 0.0002
34 DYSLIPIDAEMIA 1 0.0002
35 HYDROCEPHALUS 1 0.0002
36 CYSTIC FIBROSIS 1 0.0002
37 HEART RATE ABNORMAL 1 0.0002
38 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
39 VULVOVAGINAL BURNING SENSATION 1 0.0002
40 INFUSION SITE EXTRAVASATION 1 0.0002
41 INFUSION SITE SWELLING 1 0.0002
42 LYMPHOEDEMA 1 0.0001
43 APHONIA 2 0.0001
44 SEASONAL ALLERGY 2 0.0001
45 FAECES SOFT 1 0.0001
46 ORAL DISORDER 1 0.0001
47 HYPOPHOSPHATAEMIA 1 0.0001
48 PRODUCT USE COMPLAINT 2 0.0001
49 EMBOLISM 1 0.0001
50 EOSINOPHIL COUNT INCREASED 1 0.0001
51 GOUT 2 0.0001
52 OROPHARYNGEAL DISCOMFORT 1 0.0001
53 IRON DEFICIENCY ANAEMIA 1 0.0001
54 PRODUCT DISTRIBUTION ISSUE 1 0.0001
55 LEUKAEMIA 1 0.0001
56 HOSPICE CARE 1 0.0001
57 BLOOD PRESSURE ABNORMAL 2 0.0001
58 INITIAL INSOMNIA 1 0.0001
59 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
60 ORAL PAIN 2 0.0001
61 FISTULA 1 0.0001
62 CHOLECYSTITIS 1 0.0001
63 NOCTURIA 1 0.0001
64 TOOTH EXTRACTION 1 0.0001
65 SECRETION DISCHARGE 1 0.0001
66 INFUSION SITE PAIN 1 0.0001
67 HYPOAESTHESIA ORAL 1 0.0001
68 LYMPHOMA 1 0.0001
69 BASAL CELL CARCINOMA 1 0.0001
70 PRODUCTIVE COUGH 3 0.0001
71 OBESITY 1 0.0001
72 SCIATICA 1 0.0001
73 ABSCESS 1 0.0001
74 MUSCLE TIGHTNESS 1 0.0001
75 FUNGAL INFECTION 2 0.0001
76 MUSCULOSKELETAL DISCOMFORT 1 0.0001
77 PELVIC PAIN 1 0.0001
78 CONJUNCTIVITIS 1 0.0001
79 MIDDLE INSOMNIA 1 0.0001
80 HEPATIC CIRRHOSIS 1 0.0001
81 HERNIA 1 0.0001
82 HAEMORRHOIDS 1 0.0001
83 TRANSAMINASES INCREASED 1 0.0000
84 PRODUCT AVAILABILITY ISSUE 1 0.0000
85 LOCALISED INFECTION 1 0.0000
86 CELLULITIS 2 0.0000
87 RESPIRATORY TRACT INFECTION 1 0.0000
88 BLOOD BILIRUBIN INCREASED 1 0.0000
89 DIVERTICULITIS 1 0.0000
90 PAIN IN JAW 1 0.0000
91 INTENTIONAL DOSE OMISSION 1 0.0000
92 RED BLOOD CELL COUNT DECREASED 1 0.0000
93 LETHARGY 2 0.0000
94 CHOLELITHIASIS 1 0.0000
95 TYPE 2 DIABETES MELLITUS 1 0.0000
96 DYSURIA 1 0.0000
97 HOT FLUSH 2 0.0000
98 COLITIS 1 0.0000
99 CARDIAC FAILURE CONGESTIVE 2 0.0000
100 OEDEMA PERIPHERAL 3 0.0000
101 URINARY TRACT INFECTION 4 0.0000
102 HYPOACUSIS 1 0.0000
103 PULMONARY OEDEMA 1 0.0000
104 THROAT IRRITATION 1 0.0000
105 THERAPY NON-RESPONDER 1 0.0000
106 VISION BLURRED 3 0.0000
107 NEPHROLITHIASIS 1 0.0000
108 COUGH 6 0.0000
109 LUNG DISORDER 1 0.0000
110 SYNCOPE 2 0.0000
111 ILLNESS 2 0.0000
112 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
113 NERVOUSNESS 1 0.0000
114 DEPRESSED MOOD 1 0.0000
115 PLATELET COUNT DECREASED 2 0.0000
116 FLATULENCE 1 0.0000
117 BACK PAIN 4 0.0000
118 COVID-19 3 0.0000
119 NASAL CONGESTION 1 0.0000
120 PAIN IN EXTREMITY 5 0.0000
121 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
122 ILL-DEFINED DISORDER 1 0.0000
123 PRODUCT DOSE OMISSION 1 0.0000
124 DEHYDRATION 2 0.0000
125 DRY SKIN 2 0.0000
126 HYPOTENSION 3 0.0000
127 THERAPY INTERRUPTED 1 0.0000
128 INFECTION 2 0.0000
129 BRONCHITIS 1 0.0000
130 EPISTAXIS 1 0.0000
131 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
132 CONFUSIONAL STATE 2 0.0000
133 DRY MOUTH 1 0.0000
134 SKIN EXFOLIATION 1 0.0000
135 BALANCE DISORDER 1 0.0000
136 MUSCULOSKELETAL STIFFNESS 1 0.0000
137 INSOMNIA 3 0.0000
138 TACHYCARDIA 1 0.0000
139 HEADACHE 7 0.0000
140 ADVERSE DRUG REACTION 1 0.0000
141 OROPHARYNGEAL PAIN 1 0.0000
142 WEIGHT DECREASED 3 0.0000
143 PULMONARY EMBOLISM 1 0.0000
144 GAIT DISTURBANCE 2 0.0000
145 CONTUSION 1 0.0000
146 DRUG INTOLERANCE 1 0.0000
147 DYSPEPSIA 1 0.0000
148 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
149 CHEST DISCOMFORT 1 0.0000
150 SINUSITIS 1 0.0000
151 HAEMOGLOBIN DECREASED 1 0.0000
152 ERYTHEMA 2 0.0000
153 ABDOMINAL PAIN UPPER 2 0.0000
154 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
155 ASTHMA 1 0.0000
156 NAUSEA 7 0.0000
157 INCORRECT DOSE ADMINISTERED 2 0.0000
158 ABDOMINAL PAIN 2 0.0000
159 CHILLS 1 0.0000
160 VOMITING 4 0.0000
161 PAIN 5 0.0000
162 FATIGUE 6 0.0000
163 RENAL FAILURE 1 0.0000
164 RASH 3 0.0000
165 PRODUCT DOSE OMISSION ISSUE 2 0.0000
166 HYPOAESTHESIA 1 0.0000
167 PERIPHERAL SWELLING 1 0.0000
168 DIARRHOEA 4 0.0000
169 PNEUMONIA 2 0.0000
170 DIZZINESS 3 0.0000
171 FALL 2 0.0000
172 ABDOMINAL DISCOMFORT 1 0.0000
173 MYALGIA 1 0.0000
174 MUSCLE SPASMS 1 0.0000
175 ASTHENIA 2 0.0000
176 ANAEMIA 1 0.0000
177 PRURITUS 2 0.0000
178 ALOPECIA 1 0.0000
179 SOMNOLENCE 1 0.0000
180 HYPERTENSION 1 0.0000
181 DEPRESSION 1 0.0000
182 DECREASED APPETITE 1 0.0000
183 DEATH 3 0.0000
184 ARTHRALGIA 1 0.0000
185 MALAISE 1 0.0000
186 DYSPNOEA 1 0.0000